FibroBiologics Files New Patent For Fibroblast Tech To Advance Deeper Into Orthopedics

On Wednesday, FibroBiologics, Inc. (NASDAQ:FBLG) submitted a new patent application with the U.S. Patent and Trademark Office (USPTO).The patent application covers a proprietary fibroblast-derived therapy platform for use in orthopedic and musculoskeletal conditions, including degenerative disc repair, cartilage repair, and joint restoration.The application, if granted, strengthens the protection for the company’s fibroblast technology that leverages fibroblast cells, spheroids, and/or fibroblast-differenti ...